Avalo Therapeutics, Inc. AVTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

43/100

3/7 Pass

SharesGrow Intrinsic Value

共有 50 笔近期内部人交易记录记录，涉及 Avalo Therapeutics, Inc. (AVTX), 包括 29 笔买入 和 17 笔卖出. 内部人买入总额为 $18.97M 内部人卖出总额为 $848.54K.

近期活跃的重要内部人包括 Sullivan Christopher Ryan, Doyle Mittie, Lind Kevin Robert. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — AVTX

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2026-04-02	Sullivan Christopher Ryan	Chief Financial Officer	知情卖出	1,780	$17.57	$31.27K	17,338
2026-04-01	Sullivan Christopher Ryan	Chief Financial Officer	知情卖出	7,479	$16.83	$125.84K	25,318
2026-04-01	Doyle Mittie	Chief Medical Officer	知情卖出	679	$16.00	$10.86K	3,622
2026-03-31	Lind Kevin Robert	Director	限制性股票授予 (RSU)	1,370	$14.93	$20.45K	1,370
2026-03-31	Jain Rita	Director	限制性股票授予 (RSU)	1,339	$14.93	$19.99K	1,339
2026-03-28	Kaplan Gilla	Director	期权行权（卖出）	3,166	-	-	3,167
2026-03-28	Neil Garry Arthur	Chief Executive Officer	期权行权（卖出）	64,866	-	-	64,867
2026-03-28	Chan Mitchell	Director	期权行权（卖出）	3,166	-	-	3,167
2026-03-28	Sullivan Christopher Ryan	Chief Financial Officer	期权行权（卖出）	24,200	-	-	24,200
2026-03-28	Kantoff Aaron	Director	期权行权（卖出）	3,166	-	-	3,167
2026-03-28	Goldman Jonathan	Director	期权行权	3,166	-	-	3,166
2026-03-28	Truex Samantha	Director	期权行权（卖出）	3,166	-	-	3,167
2026-03-16	Doyle Mittie	Chief Medical Officer	知情卖出	25,492	$16.15	$411.61K	3,622
2026-02-26	Neil Garry Arthur	Chief Executive Officer	限制性股票授予 (RSU)	286,000	$17.64	$5.05M	286,000
2026-02-26	Varki Paul	Chief Legal Officer	限制性股票授予 (RSU)	80,000	$17.64	$1.41M	80,000
2026-02-26	Sullivan Christopher Ryan	Chief Financial Officer	限制性股票授予 (RSU)	105,000	$17.64	$1.85M	105,000
2026-02-26	Doyle Mittie	Chief Medical Officer	限制性股票授予 (RSU)	105,000	$17.64	$1.85M	105,000
2026-02-26	Riley Jennifer	Chief Strategy Officer	限制性股票授予 (RSU)	95,000	$17.64	$1.68M	95,000
2026-02-26	Boyd Taylor	Chief Business Officer	限制性股票授予 (RSU)	95,000	$17.64	$1.68M	95,000
2025-12-31	Lind Kevin Robert	Director	限制性股票授予 (RSU)	848	$18.16	$15.4K	848
2025-12-31	Jain Rita	Director	限制性股票授予 (RSU)	1,043	$18.16	$18.94K	1,043
2025-12-10	Varki Paul	Chief Legal Officer	RSU 预扣税	1,016	$4.10	$4.17K	3,634
2025-12-10	Sullivan Christopher Ryan	Chief Financial Officer	RSU 预扣税	155	$4.10	$635.50	17,338
2025-12-10	Doyle Mittie	Chief Medical Officer	RSU 预扣税	1,013	$4.10	$4.15K	3,622
2025-12-10	Riley Jennifer	Chief Strategy Officer	RSU 预扣税	637	$4.10	$2.61K	2,655
2025-11-14	Goldman Jonathan	Director	知情卖出	3,167	$14.30	$45.29K	-
2025-10-01	Lind Kevin Robert	Director	未知	-	-	-	-
2025-10-01	Lind Kevin Robert	Director	限制性股票授予 (RSU)	40,200	$12.96	$520.99K	40,200
2025-10-01	Boyd Taylor	Officer	未知	-	-	-	-
2025-10-01	Boyd Taylor	Chief Business Officer	限制性股票授予 (RSU)	275,000	$12.96	$3.56M	275,000
2025-09-30	Jain Rita	Director	限制性股票授予 (RSU)	1,572	$12.71	$19.98K	1,572
2025-06-17	Kaplan Gilla	Director	限制性股票授予 (RSU)	20,100	$4.47	$89.85K	20,100
2025-06-17	Heffernan Michael Thomas	Director	限制性股票授予 (RSU)	29,500	$4.47	$131.87K	29,500
2025-06-17	Almenoff June Sherie	Director	限制性股票授予 (RSU)	20,100	$4.47	$89.85K	20,100
2025-06-17	Jain Rita	Director	未知	-	-	-	-
2025-06-17	Jain Rita	Director	限制性股票授予 (RSU)	40,200	$4.47	$179.69K	40,200
2025-06-17	Chan Mitchell	Director	限制性股票授予 (RSU)	20,100	$4.47	$89.85K	20,100
2025-06-17	Kantoff Aaron	Director	限制性股票授予 (RSU)	20,100	$4.47	$89.85K	20,100
2025-06-17	Goldman Jonathan	Director	限制性股票授予 (RSU)	20,100	$4.47	$89.85K	20,100
2025-06-17	Truex Samantha	Director	限制性股票授予 (RSU)	20,100	$4.47	$89.85K	20,100
2025-03-28	Kaplan Gilla	Director	期权行权	3,167	-	-	3,167
2025-03-28	Almenoff June Sherie	Director	期权行权	3,167	-	-	3,167
2025-03-28	Neil Garry Arthur	Chief Executive Officer	RSU 预扣税	17,787	$8.46	$150.48K	47,140
2025-03-28	Chan Mitchell	Director	期权行权	3,167	-	-	3,167
2025-03-28	Sullivan Christopher Ryan	Chief Financial Officer	RSU 预扣税	7,285	$8.46	$61.63K	16,921
2025-03-28	Kantoff Aaron	Director	期权行权	3,167	-	-	3,167
2025-03-28	Goldman Jonathan	Director	期权行权	3,167	-	-	3,167
2025-03-28	Truex Samantha	Director	期权行权	3,167	-	-	3,167
2025-03-25	Heffernan Michael Thomas	Director	未知	-	-	-	-
2025-03-25	Heffernan Michael Thomas	Director	限制性股票授予 (RSU)	50,000	$8.54	$427K	50,000